[pT1G3 bladder carcinoma: our experience].
Approximately 6 to 23% of the patients with transitional cell carcinoma confined to the superficial mucosa of the bladder suffer for a pT1G3 tumor. Between 1984 and 1994, 12 patients were treated for high grade stage T1 tumores. Trans-urethral resection of the bladder cancer was performed in 8 patients, supported in two cases by immunotherapy with B.C.G. and in one case by endovesical chemotherapy. Radical cystectomy was carried out in 4 patients. Our results are similar to what reported by other Authors, but we didn't have any progression in all 8 patients treated with conservative therapy.
Dell'Orto
P
P
Clinica Urologica I, Università di Milano.
Trinchieri
A
A
D'Addezio
F
F
Bernardini
P
P
Mangiarotti
B
B
Del Nero
A
A
Pisani
E
E
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D015653:Cystectomy; D005500:Follow-Up Studies; D006801:Humans; D007167:Immunotherapy; D016685:Mitomycin / Q000627:therapeutic use; D013997:Time Factors; D001743:Urinary Bladder / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000601:surgery / Q000628:therapy*
D000903:Antibiotics, Antineoplastic; D001500:BCG Vaccine; D016685:Mitomycin
Carcinoma vescicale pT1G3: nostra esperienza.